DVA logo

DVADaVita Inc

$203.36
$4.83
(2.37%)
Today
Closed $208.66
$5.30
(2.54%)
After Hours
Updated: 04:44 PM EDT
EarningsAug 5
Mkt Cap$13.09B
Vol897,026.00
News
all
press releases
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider
In the most recent trading session, DaVita HealthCare (DVA) closed at $203.83, indicating a +2.66% shift from the previous trading day.
Zacks
News Placeholder
More News
News Placeholder
DaVita HealthCare (DVA) Moves to Strong Buy: Rationale Behind the Upgrade
DaVita HealthCare (DVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks
News Placeholder
Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?
Here is how Alignment Healthcare (ALHC) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.
Zacks
News Placeholder
Best Value Stocks to Buy for June 11th
PRTH, DVA and BFH made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 11, 2026.
Zacks
News Placeholder
Best Growth Stocks to Buy for June 11th
DVA, HRB, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 11, 2026.
Zacks
News Placeholder
EHC Expands Georgia Footprint With New 40-Bed Rehab Hospital
Encompass Health deepens its Georgia presence with a new rehab hospital as rising demand, expanding capacity and strong operating trends fuel growth.
Zacks
News Placeholder
DaVita Stock Gains From Integrated Kidney Care and CKCC Progress
DVA expands its IKC platform, tops CKCC savings in first-quarter 2026 and rolls out AI ScheduleHub to boost scheduling and staffing.
Zacks
News Placeholder
Are Investors Undervaluing DaVita (DVA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks
News Placeholder
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare
Quest Diagnostics, DaVita, LifeStance Health and Aveanna Healthcare are benefiting from telehealth, AI adoption and growing home-care demand.
Zacks
News Placeholder
4 Outpatient Home Health Stocks Benefiting From Industry Trends
An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.
Zacks
<
1
2
...
>

Advertisement|Remove ads.